These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation. Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors of renal dysfunction after liver transplant: a single-center experience. Dehghani SM; Derakhshan A; Taghavi SA; Gholami S; Jalaeian H; Malek-Hosseini SA Exp Clin Transplant; 2008 Mar; 6(1):25-9. PubMed ID: 18405241 [TBL] [Abstract][Full Text] [Related]
4. Renal function evaluated by measured GFR during follow-up in pediatric liver transplant recipients. Bishop JR; Burniston MT; Barnfield MC; Stringer MD; Prasad R; Davison SM; Rajwal S; McClean P Pediatr Transplant; 2009 Feb; 13(1):96-103. PubMed ID: 18673354 [TBL] [Abstract][Full Text] [Related]
5. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
6. Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients. Corman SL; Coley KC; Schonder KS Pharmacotherapy; 2006 Oct; 26(10):1433-7. PubMed ID: 16999653 [TBL] [Abstract][Full Text] [Related]
7. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus. Casas-Melley AT; Falkenstein KP; Flynn LM; Ziegler VL; Dunn SP Pediatr Transplant; 2004 Aug; 8(4):362-6. PubMed ID: 15265163 [TBL] [Abstract][Full Text] [Related]
8. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091 [TBL] [Abstract][Full Text] [Related]
9. Renal function outcome in pediatric liver transplant recipients. Mention K; Lahoche-Manucci A; Bonnevalle M; Pruvot FR; Declerck N; Foulard M; Gottrand F Pediatr Transplant; 2005 Apr; 9(2):201-7. PubMed ID: 15787794 [TBL] [Abstract][Full Text] [Related]
10. Renal function in pediatric liver transplant patients. McDiarmid SV Kidney Int Suppl; 1996 Jan; 53():S77-84. PubMed ID: 8770996 [TBL] [Abstract][Full Text] [Related]
11. Long-term glomerular filtration rate in liver allograft recipients according to the type of calcineurin inhibitors. Niel OR; Berthoux F; Albano L; Dahan P; Aoudia R; Gugenheim J; Cassuto E Transplant Proc; 2009 Oct; 41(8):3329-32. PubMed ID: 19857743 [TBL] [Abstract][Full Text] [Related]
12. The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation. Arora-Gupta N; Davies P; McKiernan P; Kelly DA Pediatr Transplant; 2004 Apr; 8(2):145-50. PubMed ID: 15049794 [TBL] [Abstract][Full Text] [Related]
13. Acquired renal cysts after pediatric liver transplantation: association with cyclosporine and renal dysfunction. Calvo-Garcia MA; Campbell KM; O'Hara SM; Khoury P; Mitsnefes MM; Strife CF Pediatr Transplant; 2008 Sep; 12(6):666-71. PubMed ID: 18331544 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a north american multicenter registry. Ng VL; Fecteau A; Shepherd R; Magee J; Bucuvalas J; Alonso E; McDiarmid S; Cohen G; Anand R; Pediatrics; 2008 Dec; 122(6):e1128-35. PubMed ID: 19047213 [TBL] [Abstract][Full Text] [Related]
15. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF; Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978 [TBL] [Abstract][Full Text] [Related]
16. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency. Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147 [TBL] [Abstract][Full Text] [Related]
17. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia. Almutairi F; Peterson TC; Molinari M; Walsh MJ; Alwayn I; Peltekian KM Liver Transpl; 2009 May; 15(5):504-8. PubMed ID: 19399742 [TBL] [Abstract][Full Text] [Related]